| Released | Contributor | Author | Title | Pages | Price |
|---|
| May 23, 2013 | Alpha Street Research | Hunter Orr | CVS - CVS Caremark Corp - Upgraded to a Buy - Company Analysis and ASR Ranking Report | 9 | $24 | | May 22, 2013 | New Constructs, LLC | N/A | CVS: Due Diligence Review: Forensic Earnings and Valuation | 13 | $25 | | May 22, 2013 | Thomson Reuters Stock Report | StockReports + Research Department | Thomson Reuters Stock Report - CVS CAREMARK CORPORATION (CVS-N) | 12 | $25 | | May 22, 2013 | ValuEngine, Inc. | N/A | ValuEngine Detailed Valuation Report for CVS | 11 | $126.50 | | May 22, 2013 | Stock Traders Daily | Thomas H Kee Jr. | Trading Report for (CVS). A detailed report, including free correlated market analysis, and updates. | 5 | $57.50 | | May 20, 2013 | Stock Traders Daily | Thomas H Kee Jr. | The Investment Rate - a measure of investment demand. | 43 | $494.50 | | May 19, 2013 | Pechala's Reports | Lubomir Pechala | CVS CORPORATION (CVS) - REPORT FOR ACTIVE TRADERS | 1 | $25 | | May 19, 2013 | Market Edge | N/A | Market Edge Equity Research Report | 4 | $10 | | May 17, 2013 | S&P Capital IQ – STARS Reports | N/A | CVS Caremark Corp | 10 | $115 | | May 17, 2013 | Wright Reports | N/A | Wright Investors Service Comprehensive Report for CVS Caremark Corporation | 43 | $494.50 |
|
View All Reports for CVS ... |
|
|
0.37(0.63%) 4:03PM EDT